benzoin sumatra + storax: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
benzoin sumatra + storax: clinical details
Prescribing considerations
- The selected eMC product is marked discontinued; verify the exact preparation and current availability.
- External use only. Account for ethanol content, flammability and accidental-ingestion risk.
- For inhalation, balance limited symptomatic intent against the scald risk from hot water.
- The inhalation route is unsuitable for infants under 3 months.
Contraindications and cautions
- Known hypersensitivity to Sumatra benzoin or storax.
- Do not use as an inhalant in children under 3 months.
Monitoring
- No routine laboratory monitoring is described.
- Review persistent or worsening symptoms.
- Monitor exposed skin for irritation or allergic contact dermatitis and stop treatment if these occur.
Clinical pharmacology
Sumatra benzoin has aromatic inhalant, mild antiseptic and protective properties; storax contributes mild antiseptic activity. Pharmacokinetic information is unavailable.
Formulation and product differences
- The selected product is a dark-brown, ethanol-containing tincture with aloes and purified water, supplied in a glass bottle.
- No other selected formulation is represented on this page.
benzoin sumatra + storax interactions
No interactions with other medicines are known for the licensed external routes.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.